`
`
`
`
`
`
`
`
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`GENEDX, INC.
`Petitioner
`
`v.
`
`MYRIAD GENETICS, INC.
`Patent Owner
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Case 2014-01313
`Patent 6,051,379
`
`
`
`
`
`
`
`
`
`
`PATENT OWNER MYRIAD GENETIC’S
`UPDATED MANDATORY NOTICES
`
`
`
`Case IPR2014-01313
`Attorney Docket No: 28496-0022IP1
`
`
`
`
`
`PATENT OWNER’S UPDATED MANDATORY NOTICES
`UNDER 37 C.F.R. § 42.8
`
`Pursuant to 37 C.F.R. § 42.8, the patent owner, MYRIAD GENETICS, INC.
`
`(“Patent Owner”), hereby submits the following Updated Mandatory Notices in
`
`response to the Petition for Inter Partes Review of U.S. Patent No. 6,051,379.
`
`1.
`
`Real Party-In-Interest under 37 CFR § 42.8(b)(1)
`
`MYRIAD GENETICS, INC. is the Patent Owner and the Real Party-In-
`
`Interest in this proceeding.
`
`2.
`
`Related Matters under 37 CFR § 42.8(b)(2)
`
`The following judicial or administrative matters may affect or be affected by
`
`a decision in this proceeding:
`
`Administrative Matters: Petitioner, GeneDx, has filed IPR petitions against
`
`the following patents that are either owned or licensed by Myriad Genetics:
`
`1. U.S. 7,838,237 (IPR 2014-01296);
`
`2. U.S. 7,670,776 (IPR 2014-01298);
`
`3. U.S. 7,563,571 (IPR 2014-01299);
`
`4. U.S. 7,622,258 (IPR 2014-01301);
`
`5. U.S. 5,654,155 (IPR 2014-01310);
`
`6. U.S. 6,033,857 (IPR 2014-01311);
`
`7. U.S. 6,083,698 (IPR 2014-01312);
`
`2
`
`
`
`Case IPR2014-01313
`Attorney Docket No: 28496-0022IP1
`
`8. U.S. 6,951,721 (IPR 2014-01314);
`
`9. U.S. 7,470,510 (IPR 2014-01315);
`
`10. U.S. 5,753,441 (IPR 2014-01316).
`
`Judicial matters: Patent Owner asserted the ’379 patent against GeneDx in
`
`Univ. of Utah Research Found. et al., v. GeneDx, Inc., No. 2:13-CV-00954-RJS
`
`(D. Utah), filed on October 16, 2013. The ’379 patent is also currently involved in
`
`the following judicial proceedings: Univ. of Utah Research Found., et al. v. Ambry
`
`Genetics Corp., 2:13-cv-00640- RJS (D. Utah); Quest Diagnostics Inc. et al. v.
`
`Myriad Genetics, Inc., No. 13-CV-1587-AG (C.D. Cal.); Univ. of Utah Research
`
`Found., et al. v. Quest Diagnostics Inc. et al., 2:13-CV-00967-RJS (D. Utah);
`
`Counsyl Inc. v. Myriad Genetics, Inc., No. 5:13-cv-04391-EJD (N.D. Cal.); InVitae
`
`Corp. v. Myraid Genetics, Inc., 3:13-cv-05495 (N.D. Cal.); Univ. of Utah Research
`
`Found., et al. v. Laboratory Corp. of America Holdings, 2:13-cv-01069-RJS (D.
`
`Utah); and Univ. of Utah Research Found., et al. v. Pathway Genomics Corp.,
`
`2:14-cv-000442-RJS (D. Utah). The above actions have been transferred to and
`
`consolidated for pretrial proceedings in the District of Utah by the Judicial Panel
`
`on Multidistrict Litigation. In re: BRCA1- and BRCA2-Based Hereditary Cancer
`
`Test Patent Litigation, MDL Case No. 2:14-MD-02510-RJS.
`
`3.
`
`Lead and Back-Up Counsel, under 37 CFR § 42.8(b)(3)
`
`The Patent Owner designates the following lead and back-up counsel:
`
`3
`
`
`
`LEAD COUNSEL
`Dorothy P. Whelan, Reg. No. 33,814
`3200 RBC Plaza
`60 South Sixth Street
`Minneapolis, MN 55402
`Tel: (612) 337-2509
`Email: Whelan@fr.com
`Fax:
` (612) 288-9696
`
`4.
`
`Service Information under 37 CFR § 42.8(b)(4)(i) et seq.
`
`Case IPR2014-01313
`Attorney Docket No: 28496-0022IP1
`BACK-UP COUNSEL
`J. Patrick Finn, III, Reg. No. 44,109
`3200 RBC Plaza
`60 South Sixth Street
`Minneapolis, MN 55402
`Tel: (612) 337-2554
`Email: IPR28496-0022IP1@fr.com
`Fax: (612) 288-9696
`
`Please address all correspondence and service to both counsel as listed
`
`above. Patent Owner consents to service by email at IPR28496-0022IP1@fr.com
`
`(ref.: Docket No. 28496-0022IP).
`
`
`
`
`
`
`
`Respectfully submitted,
`
`/Dorothy P. Whelan/
`Dorothy P. Whelan
`Reg. No. 33,814
`
`
`
`4
`
`
`
`
`
`Date:/September 22, 2014/
`
`
`Customer Number 26171
`Fish & Richardson P.C.
`Telephone: (612) 335-5070
`Facsimile: (612) 288-9696
`
`
`
`Case IPR2014-01313
`Attorney Docket No: 28496-0022IP1
`
`
`
`CERTIFICATE OF SERVICE
`
`Pursuant to 37 CFR §§ 42.6(e)(4) and 42.205(b), the undersigned certifies
`
`that on September 22, 2014, a complete and entire copy of this Patent Owner
`
`MYRIAD GENETIC’s Updated Mandatory Notices were provided via email, to
`
`the Petitioner by serving the correspondence address of record as follows:
`
`Eldora L. Ellison
`Deborah A. Sterling
`Ralph W. Powers III
`Sterne, Kessler, Goldstein & Fox, P.L.L.C.
`1100 New York Avenue, NW
`Washington, DC 20005
`
`Email: eellison-PTAB@skgf.com
`dsterlin-PTAB@skgf.com
`tpowers-PTAB@skgf.com
`
`
`
`
`
`
`
`
`/Jessica K. Detko/
`Jessica K. Detko
`Fish & Richardson P.C.
`60 South Sixth Street, Suite 3200
`Minneapolis, MN 55402
`(612) 337-2516
`
`
`
`5
`
`
`
`
`
`
`
`
`
`60969699.doc